Clinerion’s Patient Network Explorer and iClusion’s Trial Eye platforms both connect clinical trial sponsors with networks of partner hospitals, giving trial manager...

Government policy changes sometimes have all the subtlety of a steam roller, barreling forward without sufficient regard for everything in its path. Such is the case...

The $95 billion biotech Gilead Sciences is accelerating its effort to test a promising drug to treat COVID-19, the disease caused by the spreading coronavirus outbre...

A University of Bristol-led clinical trial to increase the identification and treatment of hepatitis C (HCV) patients in primary care has found to be effective, acce...

Clinerion’s Patient Network Explorer platform allows clinical trial sponsors to identify cohorts of patients eligible for recruitment from its global network of part...

Developing drugs to treat rare diseases is fraught with challenges; these range from trying to recruit from tiny patient populations to fill much-need clinical trial...

Multiple sclerosis (MS) patient Elizabeth Kinder tells us why she participated in a clinical trial and why the language needs to change. “You’re mad. Don’t do it. ...

Artificial intelligence hit a big milestone in January — the first drug designed entirely using artificial intelligence entered human clinical trials. The compound, ...

Clinical trial startup ClinOne is collaborating with continuous health monitoring (CHM) firm BioIntelliSense to incorporate data generated from the latter's FDA-clea...

Keck School of Medicine of USC is launching a large clinical study to determine whether a man-made antibody would slow or stop the progression of Alzheimer’s disease...